300723.SZ
Apichope Pharmaceutical Group Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 29.06
+1.01%Year over year
Reported trailing growth
- Revenue
- -21.9%
- EBITDA
- —
- EBIT
- +147.4%
- EPS
- +134.3%
- Free cash flow
- +89.6%
- Operating cash flow
- +104.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -25.8%
- EBITDA
- +12.1%
- EBIT
- +3.6%
- Net income
- +37.4%
- EPS
- +37.5%
- Free cash flow
- +90.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026